Results of the use of Heberprot-P®

Authors

  • Cecilio González Benavides Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara.
  • Liubka María Pérez Mederos Hospital Pediátrico “José Luis Miranda”, Santa Clara, Villa Clara.
  • Gleudy Peraltas Pérez Policlínico “Mártires del 8 de abril”, Quemado de Guines, Villa Clara.

Keywords:

diabetic foot/therapy, diabetes mellitus

Abstract

Introduction: diabetes mellitus is one of the most important in the twenty-first century by the high morbidity and mortality associated with complications health problems. It is a disease of major importance in terms of public health throughout the world for being one of the most common non-communicable and that has increased dramatically in the past 25 years. One of the most frequent complications of diabetic foot ulcer associated with neurological, vascular and infectious disorders.
Objective: to describe the results of Heberprot-P® in diabetic foot ulcers in patients treated in the Department of Angiology and Vascular Surgery.
Methods: an observational, descriptive, cross-sectional study was conducted among patients at "Arnaldo Milian Castro" Surgical Clinic Hospital of the City of Santa Clara, Villa Clara Province, in the period from January to December 2012.
Results: predominated male patients from 60 to 69 years and grades 2, 3 and 4 of the Wagner and the neuroinfectious criteria of Mc Cook ranking. Most of the patients had a location of your ulcer on the right lower limb and fingers. The effectiveness of treatment with Heberprot-P® was significantly high. The comparison between treated and untreated with Heberprot-P® showed that the number of major amputations of the first was much smaller.
Conclusions: Heberprot-P® therapy was effective and significantly reduced the number of major amputations in this center.

Downloads

Download data is not yet available.

Downloads

How to Cite

1.
González Benavides C, Pérez Mederos LM, Peraltas Pérez G. Results of the use of Heberprot-P®. Acta Méd Centro [Internet]. 2014 Dec. 27 [cited 2025 Jul. 1];8(4):16-23. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/192

Issue

Vol. 8 No. 4 (2014): October-December

Section

Original Articles

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).